SG/CALL/EDWARDS LIFESCIENCES/80/0.1/21.06.24 | Market Closed - Deutsche Boerse AG 15:51:41 2024-05-31 EDT | ||
| 0.68 EUR | -15.00% |
|
| Current month | -11.69% | ||
| 1 month | -11.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.68 | -15.00% |
| 24-05-30 | 0.8 | +9.59% |
| 24-05-29 | 0.73 | -.--% |
| 24-05-28 | 0.73 | -1.35% |
| 24-05-27 | 0.74 | -8.64% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 03:51 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SU2MAD |
| ISIN | DE000SU2MAD8 |
| Date issued | 2023-11-22 |
| Strike | 80 $ |
| Maturity | 2024-06-21 (20 Days) |
| Parity | 10 : 1 |
| Emission price | 0.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.78 € |
|---|---|
| Lowest since issue | 0.44 € |
| Spread | 0.01 € |
| Spread % | 1.37% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89
USD
Average target price
96.55
USD
Spread / Average Target
+11.12%
- Stock Market
- Warrants
- Warrant
